High-yield dividend stocks present an attractive alternative income source amidst market uncertainty. Pfizer Inc., one highlighted stock, remains strong with a dividend yield exceeding 5%. Post-pandemic, Pfizer faced revenue declines but reported a year-over-year revenue rise, underpinned by ongoing Covid vaccine sales and a promising oncology pipeline. With cost reductions planned, Pfizer aims to bolster its profitability. Long-term investment in dividend stocks can provide both income and potential capital gains, making them a wise choice for steady income generation.
Pfizer is a strong dividend stock with a 5% yield, making it attractive for steady income despite recent revenue fluctuations post-pandemic.
The company reported a revenue of $63.6 million in 2024, representing a 7% increase year-over-year, sustained by ongoing Covid vaccine sales.
Pfizer has a robust oncology drug pipeline with 108 candidates, including 30 in Phase 3 trials, promising future revenue growth.
Dividend-paying stocks like Pfizer are considered stable investments, offering passive income alongside potential capital appreciation over the long term.
Collection
[
|
...
]